Azurity Pharmaceuticals
azurity.com
Actively hiring
Prescription Drugs
As featured in
View 1 job
Follow
Overview
News
Technologies
Salaries
Products
People
Growth
Offices
Jobs
Financials
Funding and backers
Total raised
$1.1B
1 round on record
Latest round
$1.1B
Venture round · Mar 2026 · 6 mo ago
Team
201-500
employees, estimated range
Hiring now
27
+13 posted in 30 days
Backers
1
Audax Private Equity
The money's age
Fresh money
6 months since the last round · and hiring
Momentum
64/100
hiring for its size, a new city, in the news, fresh money
Last sign of life
this month
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Sep 28
Certified Azurity Pharmaceuticals Receives FDA Approval for Lamlique (lamotrigine) oral suspension · YahooFinance
Dec 12, 2024
Launched AZURITY PHARMACEUTICALS, INC. ANNOUNCES AVAILABILITY OF AZMIRO (testosterone cypionate) injection for intramuscular use, CIII · medindia.net
Nov 14, 2024
Certified AZURITY PHARMACEUTICALS, INC ANNOUNCES FDA APPROVAL OF DANZITEN (nilotinib) tablets, THE FIRST AND ONLY NILOTINIB WITH NO MEALTIME RESTRICTIONS · medindia.net
Tractionpublic signals, read monthly
Web presence
top 6%
of 133.2M domains by links, Common Crawl
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Venture round | Mar 2026 | $1.1B | — | Pulse 2.0 |
Backed byfrom the funds' portfolios and accelerator catalogs
Audax Private Equity Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
Validproof assists pharmaceutical companies meet their traceability obligation and ensure that their medicine makes it into the right hands.
The purpose of Idorsia is to discover, develop and bring more, innovative medicines to patients.
PleoPharma pharmaceutical company homepage, management team, product offering, contact us.
Optinose is a specialty pharmaceutical company focused on creating and bringing to market innovative products for patients with diseases…
3D screen printing pharmaceutical solutions company providing an advanced additive manufacturing platform engineered to produce…
Adare Pharma Solutions is a global technology-driven CDMO providing product development through commercial manufacturing expertise focused…
How Azurity Pharmaceuticals hires
Truth index
A 95/100
Median time to fill
29 days
Ghost roles
0%
Stale roles
0%
Reposted roles
33%
Azurity Pharmaceuticals scores A on the Alion truth index (A is best, E worst), measured over 6 open roles re-checked against its own hiring board: 0% look like ghost listings, 0% have gone stale and 33% are the same role posted again. Its roles close in a median of 29 days. It measures how much of what this employer publishes turns into a real, finite search - not the employer as a workplace. How the index is computed
Overview
Azurity Pharmaceuticals is a privately held specialty pharmaceutical company that develops and markets medicines for patients underserved by existing treatments, including many oral liquid and ready-to-use formulations. Its portfolio spans cardiovascular, neurology, endocrinology, gastrointestinal, oncology and orphan conditions, sold mainly in the United States. The company is headquartered in Woburn, Massachusetts, United States.
News
Azurity Pharmaceuticals Receives FDA Approval for Lamlique (lamotrigine) oral suspension
Ready-to-use oral liquid formulation provides an additional treatment option for appropriate patientsWoburn, MA, Sept. 28, 2026 (GLOBE NEWSWIRE) -- Azurity Pharmaceuticals, a privately held global pharmaceutical company dedicated to redefining medicine fo
Read more
Report
Azurity Announces Plans to Commercialize D-PLEX100 in the U.S. and Canada through Exclusive Partnership with PolyPid
Woburn, MA, July 21, 2026 (GLOBE NEWSWIRE) -- Azurity Pharmaceuticals, a privately held specialty pharmaceutical company, today announced plans ...
Read more
Report
QHP Capital: $1.1 Billion Continuation Vehicle Raised For Azurity Pharmaceuticals
QHP Capital has closed a $1.1 billion single-asset continuation vehicle to support its portfolio company Azurity Pharmaceuticals, providing liquidity to existing investors while positioning the business for continued long-term growth.
Read more
Report
Azurity Pharmaceuticals: $1.1 Billion Continuation Vehicle Secured To Support Long-Term Growth
QHP Capital has closed a $1.1 billion single-asset continuation vehicle for Azurity Pharmaceuticals, providing liquidity to existing investors while securing long-term capital to support the company's next phase of growth.
Read more
Report
Azurity Pharmaceuticals Announces FerabrightTM (ferumoxytol injection) Now Available in the U.S. for Magnetic Resonance Imaging of the Brain
Ferabright is the first and only iron-based contrast agent for MRI in the brain
Read more
Report
Azurity Pharmaceuticals and Sebela Pharmaceuticals Announce the Sale of Sebela's Bowel Prep Franchise to Azurity
Read more
Report
AZURITY PHARMACEUTICALS, INC. ANNOUNCES AVAILABILITY OF AZMIRO (testosterone cypionate) injection for intramuscular use, CIII
Azurity Pharmaceuticals announced today the availability of Azmiro, the first and only FDA-approved prefilled testosterone cypionate injection. Azmiro is an androgen indicated for testosterone replacement therapy in males for conditions associated with a
Read more
Report
Show more news
Tech stack
Technologies named in job postings at Azurity Pharmaceuticals over the last 12 months, by layer, with the share of postings for each.
Technologies in use
21
Postings analysed
5
Stack modernity
88/100AI adopter
Languages
Python
Databases
Snowflake
Cloud & platforms
GCP
Anthropic
OpenAI
Power BI
AI & ML
Claude
LLM
Sign in to see how your skills match this stack
Sign In
Full Azurity Pharmaceuticals tech stack
21 technologies · by team · pay by technology · changes · similar stacks
Growth
Hiring Momentum
91/100
Scaling fast
Open positions
26
13 opened / 60 closed in 30 days
Median time-to-fill
29 days
faster than 43% of the market
ATS activity
Every ~4 hours
Today
Hiring Dynamics
+100%
Hiring Focus
The percentage next to each role is its share of the company's job openings over the last 90 days; the arrow shows the shift versus the previous period.
Early Careers
47% ▲
Field & Service
23% ▼
Sales
13%
Operations
5%
Marketing
5% ▼
Analytics
2%
Actively hiring for Early Careers (+13 in 30 days)
Activity Timeline
New location: Woburn
Sep 2026
Removed Vector from stack
Sep 2026
Added Jira to stack
Sep 2026
Added Agile to stack
Sep 2026
Added Microsoft Office to stack
Sep 2026
Added Snowflake to stack
Sep 2026
Added Lightning Web Components to stack
Sep 2026
Added HIPAA to stack
Sep 2026
Added Edge AI to stack
Sep 2026
Added Apex to stack
Sep 2026
New location: Atlanta
Sep 2026
Added SharePoint to stack
Sep 2026
Offices
Where the company hires and what each office is for
Cities
4
Hiring now
2
Countries
3
Busiest office
Woburn
Loading the map
Headquarters
Builds here
Office with open vacancies
No open vacancies right now Tap a pin for the office
Woburn
United States
HQ
Woburn
2 open roles 4 posted in 90 days 10-50 est. staff
hires for Marketing, Early Careers
Raleigh
United States
Support & operations
Raleigh
14 open roles 35 posted in 90 days 7% engineering 200-500 est. staff
hires for Early Careers, Legal, Management
Hyderabad
India
Engineering / R&D
Hyderabad - Office
Zug
Switzerland
Regional office
Zug
Earlier presence
Atlanta, United States
Jobs
≈ $82k – $158k per year (Estimated) • In office • 8+ years exp • Bachelor's Degree • Raleigh
Snowflake
AI/ML
Edge AI
Cybersecurity
GDPR
HIPAA
Management
Jira
Agile
Apply
Financials
Total raised
$1.1B
Latest round
Venture - Series Unknown
Funding rounds
1
Funding rounds
| Round | Announced | Amount | |
|---|---|---|---|
| Venture - Series Unknown | 2026 | $1.1B | Details |